{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:29:56Z","timestamp":1761647396666},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.clinthera.2006.01.011","type":"journal-article","created":{"date-parts":[[2006,2,19]],"date-time":"2006-02-19T12:15:17Z","timestamp":1140351317000},"page":"118-123","source":"Crossref","is-referenced-by-count":22,"title":["Current face of acute otitis media: Microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine"],"prefix":"10.1016","volume":"28","author":[{"given":"Stephen","family":"Brunton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.01.011_bib1","series-title":"Physicians' Desk Reference\u00ae [CD-ROM]","year":"2005"},{"key":"10.1016\/j.clinthera.2006.01.011_bib2","first-page":"1","article-title":"Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: Recommendations of the advisorycommittee on immunization practices (ACIP)","volume":"49","year":"2000","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.clinthera.2006.01.011_bib3","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1086\/315383","article-title":"Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: Implication for immunizing with conjugate vaccines","volume":"181","author":"Dagan","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2006.01.011_bib4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1086\/323027","article-title":"Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in childrenwith otitis media","volume":"33","author":"Joloba","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.01.011_bib5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00006454-200209000-00015","article-title":"Pneumococcal serotypes from acute otitis media in rural Kentucky","volume":"21","author":"Block","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00006454-200101000-00007","article-title":"Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997","volume":"20","author":"Wald","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib7","first-page":"177","article-title":"Updated recommendations on the use of pneumococcal conjugate vaccine: Suspension of recommendation for third and fourth dose","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2006.01.011_bib8","first-page":"717","article-title":"National, state, and urban area vaccination coverage among children aged 19\u201335 months-United States, 2004","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clinthera.2006.01.011_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.inf.0000136868.91756.80","article-title":"Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media","volume":"23","author":"Block","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib10","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.inf.0000136871.51792.19","article-title":"Changes in frequency and pathogens causing acute otitis media in 1995\u20132003","volume":"23","author":"Casey","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2006.01.011_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptava lent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib14","first-page":"201A","article-title":"Widespread use of conjugated pneumococcal vaccine significantly reduces rates of AOM and antibiotic usage","volume":"55","author":"Block","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clinthera.2006.01.011_bib15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1542\/peds.2003-0592-F","article-title":"Population-based impact of pneumococcal conjugate vaccine in young children","volume":"114","author":"Poehling","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2006.01.011_bib16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00006454-198511000-00009","article-title":"Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media","volume":"4","author":"Harrison","year":"1985","journal-title":"Pediatr Infect Dis"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2006.01.011_bib17","first-page":"5192","article-title":"Evolving shifts in otitis media pathogens: Relevance to a managed care organization","volume":"11","author":"Pichichero","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2006.01.011_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006454-199509000-00005","article-title":"Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management","volume":"14","author":"Block","year":"1995","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.clinthera.2006.01.011_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1086\/379665","article-title":"Epidemiology of acute otitis media caused byStrepto coccus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugatevaccine","volume":"188","author":"McEllistrem","year":"2003","journal-title":"J Infect Dis."},{"key":"10.1016\/j.clinthera.2006.01.011_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","article-title":"Protective efficacy of a sec ond pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: Randomized, controlled trial of a 7valent pneumococcal polysaccharidemeningococcal outer membrane protein complex conjugate vaccine in 1666 children","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.01.011_bib21","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.34.11.2075","article-title":"Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States","volume":"34","author":"Jorgensen","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2006.01.011_bib22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997U.S. Surveillance study","volume":"43","author":"Jacobs","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2006.01.011_bib23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00006454-199910000-00018","article-title":"The promise of immunoprophylaxis for prevention of acute otitis media","volume":"18","author":"Pelton","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction ofprotein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2006.01.011_bib26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/01.inf.0000137574.28711.c4","article-title":"Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin\/clavulanate treatment for acute otitis media","volume":"23","author":"Block","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clinthera.2006.01.011_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.cll.2004.03.008","article-title":"Susceptibility of Streptococcus pneumoniae, Haemophilus in fluenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based onpharmacodynamic parameters: 1998\u20132001 US Surveillance Study","volume":"24","author":"Jacobs","year":"2004","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.clinthera.2006.01.011_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters","volume":"7","author":"Jacobs","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2006.01.011_bib29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1542\/peds.113.5.1451","article-title":"Diagnosis and management of acute otitis media","volume":"113","author":"American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media","year":"2004","journal-title":"Pediatrics"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T00:39:11Z","timestamp":1555461551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0149291806000257"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.01.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}